Related Articles
Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study
High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Plasma vascular endothelial growth factor 165 in advanced non‑small cell lung cancer
Correlation between vascular endothelial growth factor and long‑term prognosis in patients with acute myocardial infarction